Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans’ protection against the virus.
U.S. health officials late endorsed booster shots of the Pfizer vaccine for all Americans 65 and older along with tens of millions of younger people who are at higher risk from the coronavirus because of health conditions or their jobs.
Boosters will likely be offered even more broadly in the coming weeks or months, including boosters of vaccines made by Moderna and Johnson & Johnson.
That, plus continued growth in initial vaccinations, could mean a huge gain in sales and profits for Pfizer and Moderna in particular.
“The opportunity quite frankly is huge.....
Taking out the Big Pharma marketing scheme, remove the Politicians who wants to be in the spot light. Then let the FDA approve the other vaccines and then let us decide for ourselves how to proceed.
No comments:
Post a Comment